Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ALLY


Fundamental

Company: Ally Financial Inc
Sector: Financial
Industry: Credit Services
Country: USA
Exchange: NYSE
Index: -
P/E: 24.68
EPS (ttm): 1.36
Insider Own: 1.15%
Shs Outstand: 307.15M
Perf Week: -6.80%
Market Cap: 10.31B
Forward P/E: 6.19
EPS next Y: 5.43
Insider Trans: 1.29%
Shs Float: 303.65M
Perf Month: 1.18%
Income: 424.00M
PEG: 0.68
EPS next Q: 0.80
Inst Own: 93.78%
Short Float: 5.27%
Perf Quarter: -9.00%
Sales: 15.73B
P/S: 0.66
EPS this Y: 47.93%
Inst Trans: 4.00%
Short Ratio: 3.65
Perf Half Y: -5.59%
Book/sh: 38.77
P/B: 0.87
EPS next Y Percentage: 56.16%
ROA: 0.28%
Short Interest: 16.00M
Perf Year: -14.68%
Cash/sh: -
P/C: -
EPS next 5Y: 36.46%
ROE: 3.84%
52W Range From: 29.52
52W Range To: 45.46
Perf YTD: -6.75%
Dividend Est.: 1.20 (3.57%)
P/FCF: 271.45
EPS past 5Y: -16.14%
ROI: 1.61%
52W High: -26.13%
Beta: 1.12
Dividend TTM: 1.20 (3.57%)
Quick Ratio: -
Sales past 5Y: 8.04%
Gross Margin: -
52W Low: 13.75%
ATR (14): 1.18
Dividend Ex-Date: May 01, 2025
Current Ratio: 1.58
EPS Y/Y TTM: -43.64%
Oper. Margin: 4.62%
RSI (14): 45.79
Volatility W: 2.18%
Volatility M: 2.21%
Employees: 10700
Debt/Eq: 1.40
Sales Y/Y TTM: -2.99%
Profit Margin: 2.70%
Recom: 2.00
Target Price: 41.06
Option/Short: Yes / Yes
LT Debt/Eq: 0.85
EPS Q/Q: -295.74%
Payout: 66.70%
Rel Volume: 0.64
Prev Close: 33.93
Sales Surprise: -24.20%
EPS Surprise: 36.76%
Sales Q/Q: -16.13%
Earnings: Apr 17 BMO
Avg Volume: 4.39M
Price: 33.58
SMA20: -1.85%
SMA50: -1.53%
SMA200: -7.63%
Trades:
Volume: 2,828,330
Change: -1.03%

Technical:


Latest News:

Zefr Expands Pre-Impression Content Avoidance for Meta Feed and Reels, Now Globally Available somewhat bullish
ZFR

Summary: Zefr expands pre-impression content avoidance controls on Meta globally for all Zefr clients as part of Zefr Max product, providing transparency and customizability for advertisers.

Full article
2025-02-13T17:13:53Z
Pfizer Continues Cancer Rally as Adectris Label Expands to Non-Hodgkin Lymphomas somewhat bullish
PFE

Summary: Pfizer's antibody-drug conjugate Adcetris has received FDA approval for treating certain non-Hodgkin lymphomas, increasing its total number of indications to eight. The expansion allows the drug's use with lenalidomide and rituximab after two lines of systemic therapy in specific patients with large B-cell lymphoma who are not eligible for stem cell transplantation or CAR T therapy.

Full article
2025-02-13T12:30:35Z
Genesee County Costco announces opening date, partially opens for memberships somewhat bullish
COST

Summary: Costco opens new location in Genesee County, offering two membership tiers.

Full article
2025-02-13T08:49:53Z
Alibaba Becomes China's New AI Darling With $87 Billion Rally - Yahoo Finance very bullish
BABA

Summary: Alibaba Group Holding Ltd. is experiencing a resurgence in investor favor and stock price due to optimism surrounding its AI services and platform developments. Its shares have surged 46% since hitting a 2025 low on Jan. 13, greatly outperforming rivals Tencent Holdings Ltd., Baidu Inc., and JD.com Inc.

Full article
2025-02-13T00:38:25Z
Apple TV App (Finally) Launches on Android - Variety somewhat bullish
AAPL

Summary: Apple has released a native Android app for Apple TV, allowing Android users to access Apple TV+ and MLS Season Pass through the Google Play store. The app is optimized for Android devices, providing familiar features and interface to users.

Full article
2025-02-12T20:07:34Z
Pfizer call volume above normal and directionally bullish - Markets Insider very bullish
PFE

Summary: Bullish option flow detected in Pfizer (PFE) with high call volume and increasing implied volatility. Most active options are Feb-25 25 calls and 2/28 weekly 25 puts. Earnings are expected on May 7th.

Full article
2025-02-12T18:09:39Z
Why consumer experience is clinically important in health care - CVS Health somewhat bullish
CVS

Summary: CVS Health analyzed how consumer satisfaction impacts health-related outcomes, finding that highly satisfied patients are more adherent to their medications and more likely to engage with healthcare services.

Full article
2025-02-12T18:05:12Z
McDonald's Snack Wrap Is Finally Returning After Nearly A Decade—Here's What We Know somewhat bullish
MCD

Summary: McDonald's CEO Chris Kempczinski has announced plans to focus on expanding the company's chicken portfolio, with the return of Snack Wraps and introduction of McCrispy Chicken Strips to menus sometime in 2025. The chicken-based offerings are expected to help increase McDonald's market share by 2026.

Full article
2025-02-12T17:14:55Z
Pfizer call volume above normal and directionally bullish - TipRanks.com very bullish
PFE

Summary: Bullish option flow detected in Pfizer (PFE) with significant call trading volume and increased implied volatility. Most active options include Feb-25 25 calls and 2/28 weekly 25 puts. Earnings expected on May 7th.

Full article
2025-02-12T16:59:08Z
Bank of America sees strong jobs report Friday reigniting stock rally - CNBC somewhat bullish
KRE

Summary: Bank of America strategists believe that the upcoming U.S. jobs report will likely push stocks to more record highs due to expectations of a soft landing in the economy and low bar for a relief rally.

Full article
2024-09-30T16:16:07Z
Alibaba Stock: Re-Rating Catalysts Finally Kick In (NYSE:BABA) | Seeking Alpha somewhat bullish
BABA

Summary: The analyst has a beneficial long position in Alibaba's shares and is refraining from rating it as 'Buy' despite its slowly declining trend.

Full article
2024-09-30T03:12:05Z
Texas Instruments a Top Socially Responsible Dividend Stock With 2.7% Yield (TXN) somewhat bullish
TXN

Summary: Texas Instruments Inc. (Symbol: TXN) has been recognized as a Top Socially Responsible Dividend Stock by Dividend Channel due to its strong 2.7% yield and above-average 'DividenRank' statistics.

Full article
2024-09-23T12:40:55Z